Add Company
Join Now

NexMed Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NexMed's estimated annual revenue is currently $11.3M per year.(i)
  • NexMed's estimated revenue per employee is $182,500

Employee Data

  • NexMed has 62 Employees.(i)
  • NexMed grew their employee count by 3% last year.

NexMed's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M50%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M4-50%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is NexMed?

NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.

keywords:N/A

N/A

Total Funding

62

Number of Employees

$11.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17M627%N/A
#2
$9.4M62-10%N/A
#3
$8.1M625%N/A
#4
$8.1M62-10%N/A
#5
$7.5M62-10%N/A